Attention-deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that causes a notable burden on the patients, their families and society. Identifying and treating ADHD in the early stages is crucial for minimising the long-term impact of the disorder. Despite growing evidence of differences revealed by neuroimaging, neurophysiology, and genetic studies in ADHD populations, a reliable biomarker has not been shown yet. However, the use of proteomics has the potential to…
